Mr. Crawford earned a bachelor’s degree in mathematical sciences from Stanford University and an MBA from the University of Chicago’s Graduate School of Business. Over the course of his career, Mr. Crawford has been a consultant, executive officer and board member for 12 venture-backed and privately-funded technology firms. In 1981, he was the first full-time executive at International Genetic Engineering, Inc. and later was founding president of San Diego-based Corvas International, Inc., shepherding both of the companies through listings on NASDAQ. During his 12-year tenure at Corvas, Mr. Crawford raised over $200 million from equity investors and corporate alliances in his capacity as Chief Financial Officer. He served as Chief Financial Officer of Conforma Therapeutics, Cabrellis Pharmaceuticals and Phenomix Corporation.
Interviewed by Matthew Shindell, Historian, UCSD
At the time of this interview, Mr. Crawford was self-employed as a biotechnology consultant in finance and had recently left his position as Chief Financial Officer of Phenomix Corporation.